BetterLife Pharma (BETRF) Notes Payables (2011 - 2026)

BetterLife Pharma (BETRF) posted quarterly Notes Payables of $314731.5 for Q2 2026, up 2.67% quarter-over-quarter from $306543.3 in Q1 2026.

BetterLife Pharma (BETRF) Notes Payables (2011 - 2026) Analysis & Trends

BetterLife Pharma's Notes Payables history runs 11 years deep, the most recent figure standing at $314731.5 for Q2 2026.

In Q2 2026, Notes Payables changed N/A year-over-year to $314731.5; the TTM figure through Apr 2026 stood at $314731.5 (changed N/A YoY), while the FY2026 annual figure was $306543.3, changed N/A from the prior year.
Notes Payables for Q2 2026 stood at $314731.5, up from $306543.3 in the prior quarter.
The five-year high for Notes Payables was $314731.5 in Q2 2026, with the low at $201983.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	140.22 Bn	132.37 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.29 Bn	78.30 Bn	3.93 Bn
3	Argenx Se	65.17 Bn	59.98 Bn	1.37 Bn
4	Moderna	61.38 Bn	56.24 Bn	52.00 Mn
5	BeOne Medicines	42.18 Bn	37.09 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.99 Bn	27.68 Bn	992.69 Mn
7	BioNTech SE	28.45 Bn	10.05 Bn	668.28 Mn
8	Insmed	27.47 Bn	26.31 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	BetterLife Pharma	40.15 Mn	42.53 Mn	-

Download Data